Clinical impact of circulating LAPTM4B-35 in pancreatic ductal adenocarcinoma
ConclusionLAPTM4B-35 is significantly deregulated in PDAC with high diagnostic and prognostic impact as circulating tumor marker.
Source: Journal of Cancer Research and Clinical Oncology - Category: Cancer & Oncology Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Pancreas | Pancreatic Cancer | Pancreatitis | Statistics | Study